Millennium Management’s ADC Therapeutics ADCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.03M | Buy |
383,674
+218,857
| +133% | +$587K | ﹤0.01% | 3010 |
|
|
2025
Q1 | $232K | Sell |
164,817
-246,307
| -60% | -$347K | ﹤0.01% | 3582 |
|
|
2024
Q4 | $818K | Sell |
411,124
-301,277
| -42% | -$600K | ﹤0.01% | 3003 |
|
|
2024
Q3 | $2.24M | Sell |
712,401
-104,055
| -13% | -$328K | ﹤0.01% | 2482 |
|
|
2024
Q2 | $2.58M | Sell |
816,456
-193,981
| -19% | -$613K | ﹤0.01% | 2325 |
|
|
2024
Q1 | $4.54M | Sell |
1,010,437
-1,662,373
| -62% | -$7.46M | ﹤0.01% | 2045 |
|
|
2023
Q4 | $4.44M | Buy |
2,672,810
+22,559
| +0.9% | +$37.4K | ﹤0.01% | 1975 |
|
|
2023
Q3 | $2.38M | Buy |
2,650,251
+1,226,102
| +86% | +$1.1M | ﹤0.01% | 2368 |
|
|
2023
Q2 | $3.06M | Sell |
1,424,149
-369,043
| -21% | -$793K | ﹤0.01% | 2268 |
|
|
2023
Q1 | $3.5M | Sell |
1,793,192
-1,607,928
| -47% | -$3.14M | ﹤0.01% | 2164 |
|
|
2022
Q4 | $13.1M | Buy |
3,401,120
+2,980,867
| +709% | +$11.4M | 0.01% | 1341 |
|
|
2022
Q3 | $2.03M | Buy |
420,253
+362,288
| +625% | +$1.75M | ﹤0.01% | 2852 |
|
|
2022
Q2 | $461K | Buy |
+57,965
| New | +$461K | ﹤0.01% | 3947 |
|
|
2022
Q1 | – | Sell |
-40,367
| Closed | -$815K | – | 5099 |
|
|
2021
Q4 | $815K | Buy |
+40,367
| New | +$815K | ﹤0.01% | 3647 |
|
|
2021
Q1 | – | Sell |
-29,679
| Closed | -$950K | – | 4429 |
|
|
2020
Q4 | $950K | Sell |
29,679
-2,068
| -7% | -$66.2K | ﹤0.01% | 2919 |
|
|
2020
Q3 | $1.05K | Buy |
31,747
+16,860
| +113% | +$556 | ﹤0.01% | 2443 |
|
|
2020
Q2 | $697K | Buy |
+14,887
| New | +$697K | ﹤0.01% | 2571 |
|